Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

MR Solutions participates in the first SFNano & C’Nano joint meeting 2019

UK based MR Solutions presented a simultaneous 7T PET/MRI preclinical imaging system optimized for nanoparticle imaging to the first joint annual congress of the French Nanomedicine Society (SFNano), and the French national Competency Cluster in Nanoscience C’Nano which was held in Dijon in early December.

From MR Solutions 17 Dec 2019

What and why every woman needs to know about dense breasts

Two new state laws targeting breast cancer screenings and dense breasts have been passed in Illinois since 2018.

17 Dec 2019

New combination therapy can lead to durable responses in patients with multiple myeloma

An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma patients whose disease has relapsed or is resistant to other standard therapies.

17 Dec 2019

Spine surgery is safe in advanced-age patient group

Spine surgeons from seven institutions in Sapporo, Hokkaido, Japan, conducted a multicenter, prospective study of spine surgeries performed in patients 80 years of age and older.

17 Dec 2019

Extrachromosomal circular DNA can contribute to cancer development in children

Cancer development is associated with the gradual accumulation of DNA defects over time. Thus, cancer is considered an age-related disease.

17 Dec 2019

Study: Chemoradiation regimen for Stage III NSCLC is better than two tested alternatives

Lung cancer is the leading cause of cancer death in the United States and approximately 75-80% of all cases are non-small cell lung cancer (NSCLC).

17 Dec 2019

African-Americans at higher risk for cancer-associated VTE, study finds

African-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races.

16 Dec 2019

Houston Methodist scientist proposes new combination treatment for Ewing sarcoma

Ewing sarcoma, an aggressive tumor that commonly affects bones in adolescents and young adults, is diagnosed in about 225 American children and teens every year, accounting for about 1 percent of pediatric cancers.

16 Dec 2019

Evolutionarily novel genes found to be expressed in tumors

A team of scientists from Peter the Great St.Petersburg Polytechnic University (SPbPU) studied the evolutionary ages of human genes and identified a new class of them expressed in tumors -- tumor specifically expressed, evolutionarily novel (TSEEN) genes.

16 Dec 2019

Novel and targeted cellular product causes cell death in non-Hodgkin lymphoma models

Investigators at Rutgers Cancer Institute of New Jersey have found that a treatment based on a novel cellular product programmed to deliver an overabundance of chimeric antigen receptor causes cell death in non-Hodgkin lymphoma models that are sensitive or resistant to standard therapies.

16 Dec 2019

Breast-conserving treatment without surgery cannot be recommended at this time

Results from NRG Oncology's BR005 study show that breast-conserving treatment without surgery cannot be recommended, based on the study criteria of clinical complete response, radiological complete response (rCR)/near rCR, and negative tumor bed biopsies.

14 Dec 2019

Molecular subtyping of bladder tumors outperformed by standard pathology tests

While trying to develop a comparatively easy, inexpensive way to give physicians and their patients with bladder cancer a better idea of likely outcome and best treatment options, scientists found that sophisticated new subtyping techniques designed to do this provide no better information than long-standing pathology tests.

14 Dec 2019

Novel drug shows efficacy against advanced ROS1 and NTRK fusion-positive NSCLC

Pooled analysis of three phase 1 and 2 clinical trials published online ahead of print in the journal Lancet Oncology show that the drug entrectinib is effective and well-tolerated against advanced ROS1 and NTRK fusion-positive non-small cell lung cancers (NSCLC).

14 Dec 2019

Patient-reported outcomes linked to aromatase inhibitor adherence

If you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients commonly answer in cancer clinical trials, according to research findings to be presented Friday, Dec. 13 at the San Antonio Breast Cancer Symposium.

13 Dec 2019

IU researchers discover how to predict recurrence of triple negative breast cancer

Indiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and which women are likely to remain disease-free.

13 Dec 2019

Points to consider: Should germline genetic testing be offered to all patients with breast cancer?

Should germline genetic testing be offered to all patients with breast cancer? The American College of Medical Genetics and Genomics addresses this important question in a new statement published in Genetics in Medicine, "Points to Consider: Is There Evidence to Support BRCA1/2 and Other Inherited Breast Cancer Genetic Testing for All Breast Cancer Patients? A Statement of the American College of Medical Genetics and Genomics."

13 Dec 2019

New technique may lead to earlier and easier detection of mouth and throat cancer

Unfortunately, cancers that occur in the back of the mouth and upper throat are often not diagnosed until they become advanced, partly because their location makes them difficult to see during routine clinical exams.

13 Dec 2019

10-year results from clinical trial of extended letrozole therapy for women with HR+ breast cancer

In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending letrozole therapy for additional five years after five years of adjuvant endocrine therapy resulted in a statistically significant improvement in the 10-year disease-free survival (DFS) of postmenopausal women with hormone-receptor-positive breast cancer.

12 Dec 2019

Oncology social workers offer advice on managing holidays with a life-threatening illness

Stringing the lights, storming the malls and all those parties! Imagine facing these holiday demands while you're tired, sick, sad and worried: for people with cancer or other life-threatening illnesses, this time of year can often be far from merry.

12 Dec 2019

Scientists use novel technology for opening blood-brain barrier with implantable ultrasound

One of most potent drugs for treatment of glioblastoma, the most deadly type of brain tumor, can't be used in patients because of two problems. First, it can't reach its target because it's blocked by the blood-brain barrier, a microscopic structure that protects the brain from toxins in the blood. And the conventional formulation for this drug is toxic to the brain.

12 Dec 2019

Oncology News and Research

Further Reading

MR Solutions participates in the first SFNano & C’Nano joint meeting 2019

What and why every woman needs to know about dense breasts

New combination therapy can lead to durable responses in patients with multiple myeloma

Spine surgery is safe in advanced-age patient group

Extrachromosomal circular DNA can contribute to cancer development in children

Study: Chemoradiation regimen for Stage III NSCLC is better than two tested alternatives

African-Americans at higher risk for cancer-associated VTE, study finds

Houston Methodist scientist proposes new combination treatment for Ewing sarcoma

Evolutionarily novel genes found to be expressed in tumors

Novel and targeted cellular product causes cell death in non-Hodgkin lymphoma models

Breast-conserving treatment without surgery cannot be recommended at this time

Molecular subtyping of bladder tumors outperformed by standard pathology tests

Novel drug shows efficacy against advanced ROS1 and NTRK fusion-positive NSCLC

Patient-reported outcomes linked to aromatase inhibitor adherence

IU researchers discover how to predict recurrence of triple negative breast cancer

Points to consider: Should germline genetic testing be offered to all patients with breast cancer?

New technique may lead to earlier and easier detection of mouth and throat cancer

10-year results from clinical trial of extended letrozole therapy for women with HR+ breast cancer

Oncology social workers offer advice on managing holidays with a life-threatening illness

Scientists use novel technology for opening blood-brain barrier with implantable ultrasound

Industry Focus eBook - Oncology (3rd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News